Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
153M
-
Shares change
-
+3.05M
-
Total reported value, excl. options
-
$1.69B
-
Value change
-
+$1.89M
-
Put/Call ratio
-
0.53
-
Number of buys
-
136
-
Number of sells
-
-105
-
Price
-
$11.04
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2022
286 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2022.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 221 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 153M shares
of 334M outstanding shares and own 45.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (13.4M shares), PERCEPTIVE ADVISORS LLC (11.8M shares), STATE STREET CORP (11.8M shares), BlackRock Inc. (11.6M shares), Avoro Capital Advisors LLC (9.22M shares), FRANKLIN RESOURCES INC (5.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.35M shares), PICTET ASSET MANAGEMENT SA (3.63M shares), FARALLON CAPITAL MANAGEMENT LLC (3.18M shares), and AMERIPRISE FINANCIAL INC (3.01M shares).
This table shows the top 221 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.